Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
The American Surgeon, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 4, 2025
Objective This study was aimed at ascertaining the application value of abnormal prothrombin (PIVKA-II) and carbohydrate antigen 125 (CA125) in gallbladder cancer (GBC) diagnosis. Methods A total 70 GBC patients, patients with benign diseases (gallbladder stones polyps), normal health examination people were selected as malignant, benign, groups, respectively. The differences serum levels positive rates PIVKA-II CA125 compared. correlation between different clinicopathological characteristics (TNM stage differentiation degree) analyzed. receiver operating characteristic curve plotted to evaluate diagnostic for GBC, sensitivity, specificity, Youden’s index calculated. Results Serum malignant group higher vs those groups. Gallbladder stages III-IV had than I-II, poorly differentiated moderately well-differentiated patients. AUC alone combination 0.771, 0.789, 0.866, respectively, two combined that alone. Conclusion are increased have significant clinical diagnosis GBC.
Language: Английский
Citations
0Functional & Integrative Genomics, Journal Year: 2025, Volume and Issue: 25(1)
Published: April 14, 2025
Language: Английский
Citations
0Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155023 - 155023
Published: Dec. 10, 2023
Language: Английский
Citations
10Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155044 - 155044
Published: Dec. 20, 2023
Language: Английский
Citations
10Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
Citations
8